Novo Nordisk plans to lower the U.S. list price of certain Ozempic and Wegovy presentations to $675 starting January 1, 2027. The announced change is not immediate, does not cover every dose or form, and does not mean every patient will pay $675. It is a change to the drugs’ wholesale acquisition cost (WAC), or list price—not a guaranteed change to an individual’s cash or insured bill.
When do the Ozempic and Wegovy price cuts take effect?
Novo Nordisk announced the change on February 24, 2026. The new list prices are scheduled to take effect on January 1, 2027. Until then, the announcement does not itself lower the list price.
The company says the change represents an approximately 50% reduction for Wegovy and 35% for Ozempic compared with their then-current list prices. Those percentages describe list-price reductions, not a promised percentage saving for an individual patient. Novo Nordisk’s announcement provides the effective date, price, and product scope.
Which Ozempic, Wegovy, and Rybelsus presentations are included?
The announced $675 monthly WAC applies to these specific U.S. presentations:
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Repair Windows errors before they cause bigger problems3Scan for outdated or missing drivers - takes under a minute#1 Best Overall
- CONSTIPATION RELIEF FOR ADULTS ON A GLP-1 - Magnesium citrate (250 mg) pulls water into the bowel for gentle, non-cramping regularity. A daily laxative alternative built for slowed digestion: it works with your medication, not against it.
- DEBLOAT, GAS & SULFUR BURP RELIEF - Ginger root (200 mg) is a natural prokinetic that keeps food moving and cuts fermentation gas at the source, while a 19-strain probiotic blend rebuilds the gut bacteria slowed transit disrupts.
- COMPLETE GLP 1 SUPPORT IN TWO CAPSULES - 14 actives: magnesium, ginger, peppermint, 19-strain probiotics, methyl B12, B6, iron, zinc and digestive enzymes. No psyllium, no added fiber. Fiber only adds bulk to a stalled gut.
- MOST FEEL IT WITHIN DAYS - Many go within 1 to 4 days; for others it builds over the first 1 to 2 weeks. Take 2 capsules every day with your evening meal (daily use, not a rescue dose). Sensitive stomach? Start with 1 capsule for 3 days.
- PHYSICIAN-FORMULATED, THIRD-PARTY TESTED - Made in a cGMP-certified, FDA-registered facility in Utah. Free from dairy, soy, gluten, wheat, peanuts, tree nuts, eggs, fish, shellfish and artificial sweeteners. Questions? Message us anytime.
| Medicine | Presentations named in the announcement | Announced monthly WAC from January 1, 2027 |
|---|---|---|
| Wegovy | Injection 2.4 mg; tablets 25 mg | $675 |
| Ozempic | Injection 0.5 mg, 1 mg, and 2 mg | $675 |
| Rybelsus | Tablets 7 mg or 14 mg | $675 |
The announcement names these presentations; it should not be read as covering every dose, formulation, or semaglutide product.
Does $675 mean that is what patients will pay?
No. WAC is a manufacturer list-price benchmark, not necessarily the amount charged at the pharmacy or the patient’s final cost. An uninsured person’s cash price can differ from list price. An insured patient’s cost depends on plan coverage and terms such as deductibles and coinsurance, as well as pharmacy arrangements and any applicable assistance.
Novo Nordisk’s announcement does not quantify patient-level savings or say how insurers and pharmacies will respond. Axios reported that the 2027 list-price cut does not itself change the cash price for people without insurance. Axios’s February 24, 2026 report also attributed the rationale to Jamey Millar, Novo Nordisk’s executive vice president for U.S. operations, who cited learning since launch and a desire to improve affordability, particularly for patients with high deductibles or coinsurance. That is the company executive’s explanation, not a measurement of actual savings.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.How does the announced cut differ from other price routes?
Compare a medicine’s price only after identifying its type, effective date, eligible presentation, and channel or coverage terms. The announced WAC change is separate from self-pay offers and government pricing arrangements.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Rank #2
- Upgraded Cooling Effect: This diabetic travel case comes with two upgraded ice packs each weighing 90g. The insulin cooler can maintain your diabetic supplies at a suitable temperature for 4-8 hours, after being frozen for 12 hours. This diabetic supply bag provides enough cooling time for a stress-free short trip (The above results are based on ideal 25-30℃ conditions, so actual cooling time may vary with the ambient temperature）
- Ideal Size for Daily Life: This insulin travel case is compact 7.7 x 3.15 x 1.38in for easy carry. The small insulated cooler bag designed in the right size can be held with one hand easily and fit your handbag or backpack. This medication cooler is a great choice for commuting to work or school, outdoor camping or short trips
- High-Quality Insulation Materials for Insulin Safety: Made with quality Oxford fabric, thickened pearl cotton padding, and an aluminum lining, this diabetes travel case provides reliable insulation and protection, helping keep your medication cool and in safe condition during daily use or travel
- Organize What You Need: With a well-designed layout, this insulin pen cooler travel case facilitates neat storage for diabetic supplies, such as 2-3 insulin pens, refills, syringes, insulin needles or alcohol wipes. The insulated medication travel bag can pack all you need and keep them well organized when you are daily outing
- TSA Approved: The 2 x 90g ice packs meet TSA security standards and can be taken on board without hassles. Normally, one ice pack can meet your need to keep medicine cold, and the other one can be carried in your suitcase or left at home as a replacement. This insulin bag allows you to enjoy travel and makes your health management efficient and worry-free
Historical self-pay offer
Novo Nordisk’s 2025 annual report described an introductory $199 monthly self-pay offer for the first two doses, 0.25 mg and 0.5 mg, for new self-pay patients through March 31, 2026, followed by a stated standard self-pay price of $349 per month. The introductory period had ended by October 8, 2026, so it is not a current offer based on those dates. These figures describe that separate offer, not the 2027 WAC. Novo Nordisk Annual Report 2025
Government pricing framework
The same annual-report material describes a U.S. government framework intended to lower semaglutide prices across Medicare Part D, Medicaid, and direct-to-patient channels from 2026 onward, including a Medicare pilot for qualifying beneficiaries. Those arrangements are distinct from the 2027 list-price change; eligibility and terms depend on the relevant program.
Hims & Hers access agreement
On March 9, 2026, Novo Nordisk announced an agreement under which Hims & Hers customers would have access to FDA-approved Ozempic and Wegovy injectables and the Wegovy pill at Novo’s self-pay prices. This is an access-channel announcement, not the same thing as a list-price reduction. Its announcement does not establish current availability or publisher affiliate terms. Novo Nordisk’s Hims & Hers announcement
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
